Navigation Links
TNF blockers may increase the risk of malignancy in children
Date:7/29/2010

The Food and Drug Administration (FDA) received reports of malignancies in children using tumor necrosis factor a (TNF) blockers, raising concerns of an associated risk and prompting an investigation. Researchers from the FDA set out to identify all reports of malignancy in children using infliximab, etanercept, and adalimumab and their report is published in the August issue of Arthritis & Rheumatism, a journal of the American College of Rheumatology.

The FDA has approved 3 TNF blockers for use in children: Etanercept to treat juvenile idiopathic arthritis (JIA); infliximab to treat Crohn's disease; and adalimumab to treat JIA. Data suggest that certain adult populations may be at an increased risk of malignancy with TNF blocker therapy. The immunosuppressive properties of TNF blockers may also increase the risk of malignancy in children, but to what extent is unclear.

Cancer is very rare in children. According to the National Cancer Institute's Surveillance, Epidemiology, and End-Results (SEER) database, the U.S. annual incidence rate for all cancers in children ages 0󈝿 years was 16.8/100,000 compared with the rate of 469.7/100,000 for all cancers in adults, age adjusted to the year 2000 U.S. population. When 48 incidences of malignancy were identified among pediatric patients treated with TNF blockers, there was cause for concern. Study leader Peter Diak, Pharm.D., explains. "The number and rare types of malignances reported in these cases are worrisome given the underreporting of adverse events in the Adverse Event Reporting System (AERS) database, the long latency period of malignancy, and the relatively small number of pediatric patients treated with TNF blockers."

The study team searched the AERS database for all reports of malignancy in children using infliximab, etanercept, and adalimumab who initiated therapy between the ages of 0 and 18 years. The 48 cases identified included 31 following infliximab use, 15
'/>"/>

Contact: Dawn Peters
healthnews@wiley.com
781-388-8408
Wiley-Blackwell
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Study finds beta blockers alone more effective for first variceal bleeding
2. Beta Blockers May Slow Spread of Breast Cancer
3. Beta-blockers help reduce metastasis and improve survival in breast cancer patients
4. Small increases in vaccine cost can cause large gaps in protection
5. Use of decision-aid program increases safety for women experiencing abuse, researchers find
6. Wood smoke exposure multiplies damage from smoking, increases risk of COPD
7. Mayo Clinic Proceedings: Sexual abuse survivors have increased of psychiatric disorders
8. Women with gestational diabetes have increased risk of recurrence in subsequent pregnancies
9. The Laser Warehouse Increases its Inventory of Used Cosmetic Lasers to Meet Growing Demand
10. Clothing4all WOWs Yet Again With Customer Appreciation and Increased Sales
11. Legalizing marijuana in California would lower the price of the drug and increase use, study finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... 2014 Alpine, NJ resident Othon Mourkakos ... team, Zebras In Tiaras, to benefit the Immune Deficiency ... October 26, 2014 in Foley Square, New York. ... Primary immunodeficiency diseases (PI) are a group of more ... of the body’s immune system is missing or functions ...
(Date:8/28/2014)... CA (PRWEB) August 28, 2014 MarijuanaDoctors.com ... California physician, James Patel M.D. of Livermore, California. As ... best and most qualified physicians, and in accordance with ... our patients to Dr. Patel’s practice. , Initially finding ... a young age, Dr. Patel was shaped by his ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 MMAR Medical ... program is a chance for regular customers to enjoy ... without the need for a wholesale license. It’s a ... semi-professional athletic programs and others who regularly purchase medical ... , “Whether supporting your own active lifestyle or those ...
(Date:8/28/2014)... 28, 2014 The Pulmonica is a ... resonant, meditative sounds that can be felt vibrating in ... to use it – just taking long, slow, deep ... , Here are some examples of how to ... your eyes, relax, and maintain good posture. Try to ...
(Date:8/28/2014)... 28, 2014 Coveros, Inc., the ... that it has partnered with InfoZen on the ... start date of 2/4/2014 with U.S. Citizenship and ... (DHS) agency that oversees lawful immigration to the ... InfoZen will automate the integration and delivery of ...
Breaking Medicine News(10 mins):Health News:Army Colonel Dr. James Patel Joins the Medical Marijuana Industry 2Health News:Army Colonel Dr. James Patel Joins the Medical Marijuana Industry 3Health News:Army Colonel Dr. James Patel Joins the Medical Marijuana Industry 4Health News:MMAR Medical Announces Customer Membership Program 2Health News:Ever Thought of Meditating With a Harmonica; Harmonica Techs, Inventors of the Pulmonica® Pulmonary Harmonica®, Present Tips on How to Relax with Soothing Sounds 2Health News:Coveros Partners with InfoZen on USCIS Transformation Integration Award 2
... and its partner Hyderabad-based Biological E. Ltd. announced ... a pediatric phase II clinical trial for Intercell’s ... ,The randomized and controlled study aims to demonstrate ... vaccine compared to a locally produced mouse-brain Japanese ...
... the U.S. population. Nearly one-third of affected people have ... do not work well. Those who suffer from it ... biofeedback treatment can successfully retrain muscles. ,The biofeedback ... and exercise or another treatment (sham) that included muscle ...
... Responding to calls for a fair distribution of bird ... to create a global stockpile of vaccines// for developing ... great importance in the fight against avian influenza, WHO ... The Jakarta Post Thursday. ,Chan met President ...
... and Wales have been accused of being institutionally racist. ... although services are pioneers in moving towards equity, they ... challenges of a multi-cultural society. ,The "Count ... Commission, makes grim reading for people of African and ...
... during a recent influenza B epidemic in Japan showed ... drugs//, according to a study. ,Two antiviral ... drugs known as neuraminidase inhibitors, have been effective against ... evidence of the emergence of oseltamivir-resistant type A viruses, ...
... ruling in Alberta empowers pharmacists to prescribe medicines to ... will be allowed to take a decision on the ... or prescriptions given by doctors. ,Though this ... about the ability of the pharmacists to diagnose medical ...
Cached Medicine News:Health News:Biofeedback Treats One Type Of Chronic Constipation 2Health News:Biofeedback Treats One Type Of Chronic Constipation 3Health News:Chances of Tackling Racism in Mental Health Care is Still Remote 2Health News:Study Suggests Some Drug Resistance to Influenza B Medications 2
(Date:8/27/2014)... Aug. 28, 2014 China Nepstar Chain ... the "Company"), a leading retail drugstore chain in ... stores, today announced its unaudited financial results for ... Financial HighlightsFor the quarter ended June 30, 2014: ... million) compared to RMB638.8 million in the second ...
(Date:8/27/2014)... , Aug. 27, 2014 TWi Pharmaceuticals, ... approval from the United States Food and Drug ... (ANDA) for megestrol acetate 125mg/ml oral suspension, the ... is the first-to-file and under Hatch Waxman rules, ... marketing exclusivity.  TWi has completed the pre-launch preparation ...
(Date:8/27/2014)... 27, 2014 Reportbuyer.com has added ... Collaborative R&D Terms & Agreements in Pharma, ... The Collaborative R&D Terms and ... provides comprehensive understanding and unprecedented access to ... into by the worlds leading life science ...
Breaking Medicine Technology:China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 2China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 3China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 4China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 5China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 6China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 7China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 8China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 9China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 10China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 11TWi Pharmaceuticals Receives US FDA Final Approval on Generic Megestrol Acetate 125mg/ml Oral Suspension 2Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics 2Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics 3Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics 4Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics 5Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics 6Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics 7Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics 8Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics 9
... Mylan Inc. (Nasdaq: MYL ) today ... final approval from the U.S. Food and Drug Administration ... Ibandronate Sodium Tablets, 150mg. This product is the generic ... treatment and prevention of osteoporosis in postmenopausal women. ...
... YORK, March 20, 2012 Reportlinker.com ... report is available in its catalogue: ... Market: Western Europe Market Size, Segment ... http://www.reportlinker.com/p0797078/Nutraceuticals-Product-Market-Western-Europe-Market-Size-Segment-And-Country-Analysis-And-Forecasts-2007-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Nutraceutical ...
Cached Medicine Technology:Nutraceuticals Product Market: Western Europe Market Size, Segment And Country Analysis And Forecasts (2007-2017) 2Nutraceuticals Product Market: Western Europe Market Size, Segment And Country Analysis And Forecasts (2007-2017) 3Nutraceuticals Product Market: Western Europe Market Size, Segment And Country Analysis And Forecasts (2007-2017) 4
Full Handle Laseredge Implant Blade Knife, 5.2 mm angled bevel up. Blade dimension: 16.5 mm x 5.2 mm x 4.2 mm x 1.6 mm....
Full Handle Laseredge Crescent Blade Knife, angled double bevel. Blade tip dimension: 12.7 mm x 2.0 mm x 3.8 mm....
Full Handle Laseredge Stab Blade Knife, 22.5 blade. Blade tip dimension: 10.7 mm x 1.8 mm x 4.2 mm....
18 gauge straight. Fine tip. Lightweight design offers precise hemostasis. Pencil design minimizes tissue trauma and induced astigmatism. Knurled handle provides a sure grip and better manipulation....
Medicine Products: